Loading…
SEC insider activity covers quarterly filings through June 30, 2026. Later filings are not included. Reported roles do not establish current employment or current holdings. SEC filing documents, sections and filing-text search cover filings dated January 1, 2000 onward. Earlier filings are deferred until after launch.
Also known as: MARK CUBAN COST PLUS DRUG COMPANY
Firm Income Reported for This Client
$111K
Not substituted for client expenses
Contract Awards
$1.6M
2 awards
Summary
MARK CUBAN COST PLUS DRUG COMPANY, PBC is an organization. Its political footprint includes $111K in lobbying-firm income reported for this client, $1.6 million in government contracts. Lobbying activity focuses on Health Issues. Their largest government contract source is Department of Defense at $1.6 million. Political activity spans from 2020 to 2026.
These are different money flows and are not added together: contributions and lobbying expenses flow out, while contract awards flow to the organization.
Activity data: USAspending.gov